Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNSHINE: Adjuvant S-1 after neoadjuvant DCS and esophagectomy for cStage II–III thoracic esophageal cancer
jRCTs051200048Phase 2Active, not recruiting
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in esophageal cancer. Primary endpoint: Recurrence-free survival. Started Dec 2020; status: active, not recruiting.
02
Drugs
tegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCTs051200048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200048.